Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers
Protocol ID
LOXO-EXT-17005
Disease (Sub Disease)
Solid tumours
Diagnosis Stage
Relapse/ refractory
Location
VIC
Sponsor
Bayer
Trial Status
Open
Sites
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
1 Month and older
International registry ID's
NCT03215511
Back to Registry
Study Title A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers
Protocol ID LOXO-EXT-17005
Disease (Sub Disease) Solid tumours
Diagnosis Stage Relapse/ refractory
Location VIC
Sponsor Bayer
Links https://clinicaltrials.gov/ct2/show/NCT03215511
Trial Status Open
Trial Open Date 11/07/2018
Sites Royal Children's Hospital
Study Type Treatment
Phase Phase 1/2
Age Eligibility 1 Month and older
International registry ID's NCT03215511